Drug
Rimonabant
Rimonabant: highest development phase Phase 2, developed by Sinfatin S.L. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Sinfatin S.L
Trials
| Drug | Phase | Indication |
|---|---|---|
| Rimonabant NCT07930637 | Phase 2 | Post-COVID-19 Syndrome |
Latest
No recent events.
Follow Rimonabant on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.